Skip to main content
. 2021 Aug 2;17(1):71–74. doi: 10.30699/ijp.2021.528077.2615

Table 1.

Hepatitis A and E virus antibodies level in COVID-19 patients and uninfected controls

Coronavirus infected patients (n = 45)
Median (IQR)
Control group (n = 45)
Median (IQR)
P-value
HAV Ab level* 13.6 (5.4) 13.2 (4) 0.1
HEV Ab level* 6.7 (1.8) 7.1 (1.3) 0.41

* Interpreted as the ratio of the cut-off value and the OD450nm of the sample (Co/S)